Ganda Rash uye Zvimwe Zviratidzo Pamusoro paTarceva (Erlotinib)
Kana iwe wakambosangana nemapurisa akafanana nemapurisa, ganda rakaoma, itching, uye nail kushandurwa paunotora Tarceva (erlotinib) iwe hausi woga. Kune vamwe vanhu vane mutsa wemapapu, chirwere chinonzi Tarceva (erlotinib,) uye mamwe epidermal kukura factor receptor (EGFR) inhibitors, vave kushamiswa mishonga nenzira yevanhu vane EGFR yakanaka yekenza yemapapu. Iyi mishonga yakagadzirisa hupenyu hwehupenyu huri kurarama nekenza, kupona, uye kazhinji kacho ine zvishoma zvinokonzera kupfuura tsika dzechikemotherapy .
Chimwe chikamu chinopisa, zvisinei, chakagamuchirwa zvizhinji: zvinetso zveganda
Ruzhinji rwevanhu vachishandisa mishonga Tarceva (uye dzimwe EGFR inhibitors) kukura nekukurumidza, uye zvinonakidza, kuonekwa kwekuputika kwakave kwakabatana nekupindura kumushonga. Sezvo iyi mishonga inowanzotorwa kwenguva yakareba, zvakakosha kukurukura kutungamira kwezvimwe zviratidzo zvisingafadzi neo oncologist yako.
(Kana iwe une kenza yemapapu, kunyanya mapapu adenocarcinoma, iva nechokwadi chokuti chiremba wako akaita zviratidzo zvemajini (kufungidzira kwema molecular) yemarara yako.)
Ndechipi Chine Matambudziko Eganda Anowanzobatana naTarceva (Erlotinib)?
Zvinetso zveganda zvinowanikwa nevanhu paTarceva (uye mamwe epidermal growth factor inhibitors) zvinosanganisira:
- An acneiform rash) - Iri rash rinowanzofanana neyamachena inowanikwa mumakore ekuyaruka. Iyo inowanzobatanidza chiso, nzvimbo iri shure kwe nzeve, mutsi, igomo repamusoro mu muenzaniso wakaita seV, uye scalp. Kakawanda kazhinji inobata kumucheto kumashure, mimba, mapako, uye kumusoro uye pasi. Izvozvi hazvisi kuitika pazvanza zvemaoko kana tsoka. Dermatology terminology inogona kuvhiringidza kana iwe ukaverenga ruzivo pamusoro pechisimba ichi, asi tsanangudzo shoma shoma dzinogona kubatsira. A papule zvinongoreva kugumbuka paganda. Pustule zvinoreva bump inotarisa pus inogutswa kana iri kunyura. Izwi rokuti follicular zvinongoreva kuti maronda eganda ari pedo kana muhuputi hwebvudzi.
- Danda rakasviba (xeroderma)
- Itching (pruritis)
- Unhu hwakakomberedzwa nheyo yekona kana kuti inenail (paronychia)
Ko Rash
Vanhu vazhinji vanorapwa nemishonga yakadai saTarceva vane nyoro kusvika pakuenzanisa ganda rekuputika, kazhinji kacho rudzi rwekumhanyisa runofanana nemakwenzi, uye ganda rakaoma.
Mhedziso Yeganda Zvinetso zveTarceva
Zvinetso zveganda pane epidermal kukura factor receptor inhibitor zvinogona kuchinja zvakanyanya muviri nehupenyu hwehupenyu hwevanhu vanotora mishonga iyi.
Imwe tsvakurudzo yakawana kuti idzi migumisiro yemigumisiro yakakanganisa hutano, hunobata, humwe, uye hukama hwehutano hwevarwere pamishonga. Kunyanya kunetseka kwaiva pamusoro pezviratidzo zvepanyama, kusanganisira kurwadziwa, kunzwa kunopisa, uye kunzwa.
Rash Inosvika Rini uye Inosvika Rini?
Kushanda kweganda paTarceva kazhinji kunotanga mavhiki masere kusvika kwemaviri mushure mokurapa yatanga, vari pamavhiki avo maviri kusvika matatu mushure mokurapa yatanga, uye zvingagadzirisa zvishoma nezvishoma kana kupera zvachose pamwedzi inotevera kusvika ku3. Kuziva kuti kukanganisa kunowanzovandudza nekufamba kwenguva kwakabatsira vamwe vanhu kukunda zviratidzo.
Rash Inoreva Kuti Tarceva Inoshanda Zvakanakisisa Here?
Zvidzidzo zvinoratidza kuti vanhu vanokurumidza kurwisa mishonga vane mhinduro yepamhanho yepamusoro uye zviri nani kupona. Nemhaka yeizvi, uye nokuti mishonga inowanzotorwa kwenguva yakareba, zvakakosha kuti iite zvakanaka mukurapa zviratidzo zvehushoni.
Zvinetso zveganda zvine chokuita nemamwe mishonga yemukenza zvakadai sechimotherapy uye remishonga inonzi radiation inogona kuvapo pamwe chete nevaya vanobva kuTarceva uye inofanira kutariswa zvakanyatsotarisana neoncologist yako.
Kuoma kweRash
Acne type rashes nemhaka yeTarceva inowanzoputsika kusvika muzvikamu zvitatu:
- Mucherechedzo: Tarceva ine unyoro inotsanangurwa seimwe isina kuora (nzvimbo yakazaruka) kuchema (mvura yakasviba) kana utachiona. Vanhu kazhinji vane zviratidzo zvishoma zvishoma uye hazvipindirani nemabasa ehupenyu huripo.
- Mutevedzeri: Kushandiswa kwemaTarceva kunonzwisisika kungave kunowanikwa munzvimbo ino kana kuwanda. Pane kazhinji kusina kuora, kuchema, kana utachiona. Zvinyoro zvishoma zvekuenzanisa zviratidzo zvekuchenesa uye unyoro zvinogona kunge zviripo, asi pane kungopindira zvishoma nemabasa ehupenyu.
- Zvakanyanya: Tsvuku yakawanda yeTarceva inowanzotanga (yakavhara chiso, chikamu chepamusoro, uye kumusoro kumusoro) uye kazhinji inobatanidza nezviratidzo zvakakomba zvekuchenesa uye unyoro. Iyo inobatsira zvikuru mararamiro ehupenyu. Ikoko kunogona kuva nekuonda (maronda akazaruka) kuchema (kunyura) uye zviratidzo zvechirwere chechipiri cheganda zvakadai sehutsvuku, tsvuku kana kubuda kwemavara, uye fever.
Ko Ganda Rinosvibisa Sei Kubva Tarceva Rakatorwa?
Maitiro ako ekurashwa achabatwa achavimba nehukuru hwekukurumidza, uyewo zvaunofarira. Kunyangwe chikafu chichiita sechikafu, hachisi chirwere chinopisa, uye hachizopinduri kune mamwe maitiro ekurapa.
Tarceva (Erlotinib) Rash Prevention uye Daily Care
Nhanho yekutanga mukutarisira ndeyekudzivirira: Maitiro ekudzivirira anosanganisira kuchengeta ganda rakachena, kudzivirira kupisa kwezuva, uye kushandisa nyuchi kuti uchengetedze ganda rako. Iyo yakanakisisa kubheji yekudzivirira kuvhara kwezuva ndeyokudzivirira zuva rakananga masikati masikati, uye kushandisa zvipfeko zvinodzivirira, sezvinoita sunscreens uye kunyanya kuvhara kwezuva kunogona kuita kuti Tarceva-inokonzerwa nehuputi yakaipa. Kushanda kwechimbichimbi nemaselini evaseline kunogonawo kukonzera bvudzi follicle kuvhiringidza uye kuwedzera kupisa. (Tarisa mazano aya pamusoro pekuchengetedzwa kwezuva panguva yekurapa kenza .)
Zvakakosha kucherechedza kuti kurapwa kwechimwe chiratidzo chinopindirana neTarceva kunogona kukuvadza chimwe chiratidzo uye vise versa. Semuenzaniso, mikoko inogona kubatsira nekuoma uye kubvisa asi kunowedzera zvakanyanya acne type rash.
Tarceva (Erlotinib) Rash Treatments
Kurapa kweharuti yeTarceva inobva pakuti kana kuti kwete chirwere chacho chinotapukirwa, uye chinogona kusanganisira zvose kubata chirwere, kana kugadzirisa chirwere chacho. Izvi zvingasanganisira:
Mishonga yezvirwere:
- Mishonga yepamusoro: Mifananidzo inorwisa mabhakitiriya yakadai se clindamycin uye / kana inoridhodhi hydrocortisone inowanzoshandiswa kutanga ye-acne-type Tarceva rash. Zvidzidzo zviri kutarisa kushandiswa kwevitamini K cream, uye epidermal kukura mafuta mafuta, ayo ose akaratidza chivimbiso mumakiriniki ekuedza. Zvakakosha kuti uone zvakare kuti kunyange chikafu chichifananidza nenyuchi, hachisi, uye marapirwo mazhinji emakwenzi haazobatsiri nekukurumidza.
- Mishonga yemumuromo: Kana mishonga yemazamu isingakwanisi, mishonga inorapwa nemutachicline yakasiyana-siyana mishonga inogona kushandisa. Dzidzo dziri kutarisa kushandiswa kwemishonga, sezvinonzi muromo minocycline semushonga weprophylactic; kutanga kusati kwatanga kuitika.
Kurapa kweRash Pamwechete: Kana zviratidzo zvinosanganisira kuputika kwega kwega pasina zviratidzo zvehutachiona, zvinorapwa ne-topical steroids, 1% hydrocortisone, kana 2.5% kana kupisa kwakanyanya. Muchiitiko ichi, pane kubwinya asi hapana magweta anoratidza kuti chirwere chiripo.
Kurapwa kweRash Infected: Kana rash Tarvava yakakomberedzwa nechirwere chechipiri chebhakitiriya hakusi kubwinya chete asi kazhinji zviratidzo zvehutachiona hwakadai sehuchena. Kana izvi zvikaitika, kurapa kunofanira kusanganisira zvose muromo wemishonga inorwisa mabhakitiriya (tetracyclines) pamwe nesheji yeplindamycin gel.
Kuenzaniswa kwezviyero : Inenge 10 kubva muzana yevanhu vanokura nekukurumidza kunoda kushandiswa kwemishonga. Nhamba "inowanzo" yeTarceva ine 150 mg zuva nezuva. Your oncologist inogona kufunga kuderedza chirwere ichi ku 100 mg kana kunyange 50 mg zuva rega rega. Izvi zvinogona kutyisa, kunyanya kana mishonga ichikushandira zvakanaka iwe. Izvo zvinogona kubatsira kuziva kuti kunyange kunyanya kuderera kweTarceva, kwakaderera se 25 mg zuva nezuva, kwakashanda mukurapa vamwe vanhu vane kenza yemapapu.
> Sources:
> American Society of Clinical Oncology. Cancer.net Kugadziriswa Kweganda Kurapa Kuchengetedzwa. Akawana 05/2016. http://www.cancer.net/navigating-cancer-care/side-effects/skin-reactions-targeted-therapy-and-immunotherapy
> Burotto, M., Manasanch, E., Wilkerson, J., naT. Fojo. Gefitinib uye erlotinib mune mastrasi isina simba duku yemapapu emapapu: meta-kuongorora kuora uye kushandiswa kwemaitiro emakiriniki akasiyana-siyana. Oncologist . 2015. 20 (4): 400-10.
> Califano, R. et al. Expert Consensus on the Management of Evil Evil from EGFR Tyrosine Kinase Inhibitors mu UK. Zvinodhaka . 2015. 75 (12): 1335-48.
> Fabbrocini, G., Panariello, L., Caro, G., uye S. Cacciapuoti. Acneiform Rash Inokurudzirwa neEGFR Inhibitors: Kudzokorora kweMabhuku uye Mitsva Inonzwisisika .. Matambudziko eClub Appendage . 2015. 1: 31-37.
> Hwang, I. et al. Chikamu II chirwere chepidermal kukura chinonhuwira kuvarwere vane Erletinib-ane chokuita nemagariro echechi. Kuchengetedza Kuchengetedza muCancer . 2015 Jun 4. (Epub mberi kwekudhinda).
> Kiyohara, Y., Yamazaki, N., na A. Kishi. Erlotinib-yechirwere cheshuga yehupenzi: maitiro ekurapa kune varwere vane mastasti isiri duku duku yemukenza wemapapu. Nyaya yeAmerican Academy yeDermatology . 2013. 69 (3): 463-72.
> Ocvirk, J., Heeger, S., McCloud, P., naRo Hofheinz. Kuongororwa kwemaitiro ekurapa kwechikwata cheganda chinokonzerwa neEGFR-chinotarisirwa mazano: Uchapupu kubva pamakiriniki emakirini anoedzwa uye meta-analysis. Radiology uye Oncology . 2013. 47 (2): 166-75.
> Passaro, A. et al. kutungamira kwee-nonhematologic toxicities inosangana neEGFR-TKIs dzakasiyana-siyana muNSCLC yakapfuura: kuenzanisa kuenzanisa. Clinical Lung Cancer . 2014. 15 (4): 307-12.
> Shinohara, A. et al. Kubudirira kweprophylactic minocycline kurapwa kweganda kunokonzerwa ne erlotinib pamwe gemcitabine kune varwere vane kenza yakakura yepancreatic: retrospective study. American Journal of Clinical Dermatology . 2015. 16 (3): 221-9.
> Szejiniuk, W., McCullock, T., uye O. Roe. Kubudirira kwe-ultra-low doses ye erlotinib kune varwere vane EGFR inosimudzira kuchinja. BMJ Case Reports . 2014. Nhai: 10.1136 / bcr-2014-204809.